Lipid nanoparticles have emerged as the leading non-viral delivery platform for nucleic acid therapeutics, vaccines, and gene-editing cargoes. Yet the in vivo fate of any LNP formulation — where it travels, which organs it accumulates in, what cell types internalize it, and how long it persists — is rarely predictable from formulation parameters alone. Biodistribution is determined by a chain of events: ApoE adsorption in plasma, receptor-mediated hepatocyte uptake, splenic filtration, renal clearance, lymphatic drainage, and cell-type-specific internalization kinetics. Without direct visualization, researchers must rely on indirect readouts (gene expression, biomarker modulation) that confound LNP delivery with downstream pharmacology.
Fluorescent labeling solves this measurement problem. By attaching a fluorophore to the LNP itself or to its cargo, the physical location of the particle becomes directly observable through fluorescence imaging, flow cytometry, and microscopy. The resulting biodistribution data informs critical development decisions:
Target validation: Confirming whether an LNP reaches its intended tissue (tumor, liver, spleen, lymph node, lung, brain) at therapeutically meaningful levels before investing in efficacy studies.
Off-target profiling: Quantifying unintended accumulation, most notably the dominant liver sink driven by ApoE/LDLR uptake, which routinely captures 50-80% of systemically administered LNPs.
Formulation optimization: Comparing biodistribution profiles across ionizable lipid variants, PEG-lipid chemistries, particle sizes, and surface modifications to identify the formulation window with the best target-to-background ratio.
PK/PD correlation: Linking fluorescence-derived exposure data to functional outcomes (protein expression, gene editing, antigen-specific immune response) to establish dose-response relationships.
Lipophilic carbocyanine dyes — the DiO/DiI/DiD/DiR family — are the most widely used fluorophores for LNP biodistribution studies. These planar, cationic chromophores insert spontaneously into the hydrophobic interior of the lipid bilayer, producing brightly fluorescent LNPs without requiring chemical conjugation. Their spectral series spans the visible to near-infrared window, allowing multi-channel imaging and matching of dye choice to instrument and tissue depth requirements. For laboratories seeking a fast, scalable labeling route compatible with most standard LNP compositions, carbocyanine dyes remain the default entry point and are available via fluorescent-labeled lipid nanoparticle preparation services.
Carbocyanine dyes partition into the lipid bilayer through hydrophobic and electrostatic interactions between their conjugated double bond core and the lipid acyl chains. Two incorporation strategies are commonly used:
Co-formulation: The dye is dissolved in the organic lipid phase at the start of microfluidic mixing. It becomes embedded throughout the bilayer as the LNP self-assembles, producing a uniformly labeled particle. This method is fast and reproducible but requires the dye to be soluble in ethanol and stable under the rapid mixing conditions used for LNP assembly.
Post-insertion: Pre-formed LNPs are incubated with dye in aqueous suspension at 37 °C, allowing the hydrophobic dye to diffuse into the bilayer over 30-120 minutes. Post-insertion minimizes dye exposure to organic solvents and is preferred when dye stability under mixing conditions is uncertain. It also allows parallel labeling of pre-existing LNP stocks without re-formulation.
A typical preparation protocol follows these steps: dissolve ionizable lipid, helper lipid, cholesterol, and PEG-lipid in ethanol at the desired molar ratio (commonly 50:10:38.5:1.5 mol%). Add the carbocyanine dye to the ethanol phase at 0.1-2 mol% of total lipid. Mix the ethanol phase with aqueous buffer (typically pH 4.0 citrate for ionizable lipid systems) at a 1:3 ratio on a staggered injection micromixer or equivalent microfluidic platform. Dialyze or use tangential flow filtration to remove ethanol and exchange into PBS. The dye-to-lipid ratio is the dominant parameter controlling fluorescence intensity without causing self-quenching. Loading above 1-2 mol% frequently produces concentration-dependent quenching and can perturb bilayer packing. Particle size, PDI, and EE% should be re-measured after labeling to confirm that the dye incorporation has not destabilized the formulation. For scalable workflows, microfluidic LNP production services provide consistent flow control that maintains uniform dye distribution across batches.
Fluorescent LNPs are typically characterized by three orthogonal readouts. Fluorescence spectroscopy confirms dye incorporation by measuring excitation and emission spectra; any shift relative to free dye suggests altered dye environment. Dynamic light scattering re-verifies particle size and PDI post-labeling. Encapsulation efficiency of the cargo should be re-measured to confirm the labeling step has not compromised payload retention. For in vivo biodistribution evaluation, the labeled LNPs are administered to animals via the intended route, and whole-body imaging is performed at predetermined time points. Tissue-level biodistribution is quantified by harvesting organs, homogenizing them, and measuring fluorescence in a plate reader. For cellular-level resolution, flow cytometry on dissociated tissues identifies which cell populations (hepatocytes, Kupffer cells, endothelial cells, immune subsets) have internalized the LNP. A coordinated characterization workflow is offered via lipid nanoparticle characterization services that integrate fluorescence, physicochemical, and functional readouts.
Carbocyanine-labeled LNPs are widely used for rapid biodistribution screening during formulation development, organ-level accumulation comparisons across LNP compositions, and short-term tracking studies (typically 0-72 hours). Their main limitations are dye dissociation from the bilayer over extended time periods, which produces free-dye background that can be misattributed to intact LNP, and limited stability under prolonged storage. DiN-DR is best suited for short-term studies and rapid formulation comparisons where the speed of labeling outweighs the need for long-term signal stability.
Table 1. Lipophilic Carbocyanine Dye Selection for LNP Biodistribution Studies.
| Dye | Ex / Em (nm) | Spectral Region | Recommended Incorporation | Optimal Dye-to-Lipid | Best Suited For |
| DiO | 484 / 501 | Green | Co-formulation | 0.5-1.0 mol% | Cellular uptake by flow cytometry; confocal imaging of fixed cells |
| DiI | 549 / 565 | Orange | Co-formulation or post-insertion | 0.5-1.0 mol% | In vitro tracking; multi-channel co-localization with green fluorophores |
| DiD | 644 / 665 | Far-red | Co-formulation or post-insertion | 0.3-0.8 mol% | Tissue-level imaging with reduced autofluorescence; multi-channel studies |
| DiR | 748 / 780 | Near-infrared | Co-formulation or post-insertion | 0.3-1.0 mol% | Whole-body imaging; deep-tissue biodistribution; standard for rodent small-animal fluorescence imaging studies |
BOC Sciences supports the complete workflow of co-formulation or post-insertion labeling with carbocyanine dyes, including dye-to-lipid ratio optimization, fluorescence stability assessment, and integrated biodistribution evaluation.
Near-infrared cyanine dyes — particularly cyanine 5, cyanine 5.5, and cyanine 7 — extend LNP tracking beyond the optical limits of carbocyanine dyes. Operating in the 650-800 nm window, NIR cyanines benefit from dramatically reduced tissue autofluorescence, deeper photon penetration via reduced scattering and absorption, and superior signal-to-noise for whole-body imaging of small animals. Because NIR cyanines carry sulfonate groups and are water-soluble, they cannot passively partition into the lipid bilayer and must be conjugated to a lipid anchor before incorporation. This requirement shifts the labeling chemistry but delivers LNPs with stable, covalent fluorophore attachment suitable for long-term tracking. Working with nanoparticle functionalization services experienced in lipid-dye conjugation is often the most efficient route to a high-quality NIR-labeled LNP.
NIR cyanine dyes are conjugated to lipid anchorsvia one of three chemistries:
Amine-NHS ester coupling: The cyanine's free amine reacts with an NHS-activated lipid (commonly DSPE-PEG-NHS) to form a stable amide bond. This chemistry is robust, widely available, and compatible with most dye-lipid pairs.
Maleimide-thiol coupling: Maleimide-functionalized lipids couple selectively with thiol-modified cyanines, providing site-specific conjugation under mild aqueous conditions.
Click chemistry (copper-free azide-alkyne cycloaddition): DBCO-functionalized lipids react with azide-functionalized cyanines, providing the highest conjugation specificity for sterically demanding systems.
The resulting dye-lipid construct is purified by HPLC or dialysis to remove unconjugated dye before LNP formulation. Conjugation efficiency is quantified by UV-Vis spectroscopy against a standard curve, with target efficiency above 80% for production-grade material.
The dye-lipid conjugate is incorporated into the LNP at the ethanol phase of microfluidic mixing, typically at 0.1-1.0 mol% of total lipid. Higher loading is rarely beneficial because NIR cyanines are bright emitters and excess dye increases background without proportional signal gain. After microfluidic assembly and buffer exchange, the labeled LNP should be characterized for size, PDI, zeta potential, and fluorescence intensity. A calibration curve constructed from serial dilutions of the labeled LNP enables conversion of tissue fluorescence readings to dye concentration and ultimately to %ID/g values. Optimization of the dye-to-lipid ratio for each NIR cyanine is important; loading conditions optimized for cyanine 5 frequently underperform with cyanine 7, whose longer wavelength emission is more sensitive to particle packing.Standard lipid nanoparticles formulated with optimized dye-lipid constructs are particularly valuable for direct head-to-head imaging studies.
NIR cyanine-labeled LNPs are characterized by the same orthogonal battery described for carbocyanines, with the addition of NIR plate readers or small-animal fluorescence imaging systems equipped with appropriate filter sets. For in vivo biodistribution evaluation, NIR imaging at multiple time points (typically 1, 4, 24, 48, and 72 hours post-administration) tracks the temporal trajectory of LNP accumulation and clearance. Because NIR signals penetrate several millimeters of tissue, deep-organ accumulation (liver, spleen, kidney) can be quantified non-invasively without animal sacrifice at each time point. At study termination, ex vivo imaging of harvested organs provides higher-resolution quantification, and flow cytometry of single-cell suspensions from key tissues identifies cell populations that have internalized the LNP. These workflows are supported via nanoparticle in vivo distribution analysis services that integrate imaging, tissue harvest, and quantitative readouts.
NIR cyanine-labeled LNPs are the workhorse for whole-body biodistribution studies in rodents, quantitative organ-level comparisons across formulation libraries, and long-term tracking studies (1-14 days) where dye dissociation would compromise data quality. Their limitations are higher cost per dye and the requirement for conjugation chemistry, which adds preparation steps relative to carbocyanines. They are particularly valuable when deep-tissue quantification, multi-day imaging, or spectral separation from common green/red fluorophores is required.
Table 2. Near-Infrared Cyanine Dye Selection for LNP Biodistribution Studies.
| Dye | Ex / Em (nm) | Tissue Penetration | Conjugation Chemistry | Recommended Dye-to-Lipid | Best Suited For |
| Cyanine 5 | 646 / 662 | Moderate (5-10 mm) | Amine-NHS or maleimide | 0.3-0.8 mol% | High-sensitivity far-red imaging; multi-channel studies with green fluorophores |
| Cyanine 5.5 | 673 / 707 | Good (8-12 mm) | Amine-NHS or maleimide | 0.3-0.8 mol% | Standard NIR whole-body biodistribution; deep-tissue organ imaging |
| Cyanine 7 | 750 / 776 | Excellent (12-18 mm) | Amine-NHS (slower kinetics) | 0.2-0.6 mol% | Deep-tissue imaging; spectral separation from cyanine 5/cyanine 5.5 in multiplexed studies |
| Near-Infrared Cyanine Dye Derivatives | 774 / 789 | Excellent (12-20 mm) | Amine-NHS (kit-form) | 0.2-0.5 mol% | Highest-sensitivity NIR; validated for clinical-grade imaging reagents |
BOC Sciences provides lipid-dye conjugate synthesis, dye-to-lipid ratio screening, and integrated NIR imaging evaluation across cyanine 5, cyanine 5.5, cyanine 7, and near-infrared cyanine derivatives platforms.
Fluorophore-conjugated lipids are purpose-synthesized molecules in which a fluorophore is covalently attached to a lipid anchor (commonly a diacyl glyceride, sphingoid, or sterol backbone) before LNP formulation. Examples include NBD-PE, fluorescent cholesterol derivatives, labeled phospholipids, and boron-dipyrromethene fluorophore–lipid constructs. Unlike carbocyanine dyes, these conjugates are intrinsically amphiphilic: the lipid anchor ensures stable bilayer integration, while the fluorophore projects into either the aqueous phase or the bilayer interior depending on its chemistry. This stability makes conjugated lipids the preferred choice for quantitative, long-term biodistribution studies where signal integrity over multiple days is required. Researchers requiring defined stoichiometry and stable fluorophore retention often specify custom synthesis of dye-lipid conjugates with controlled anchor length and fluorophore position.
The covalent lipid-fluorophore bond eliminates the dye dissociation that limits carbocyanine and post-insertion strategies. Three anchor architectures dominate:
Headgroup-labeled phospholipids: The fluorophore is attached to the headgroup region (e.g., NBD-PE), projecting the dye into the aqueous phase. These conjugates are well-suited for monitoring LNP-cell surface interactions and early internalization events.
Acyl chain-labeled phospholipids: The fluorophore is embedded within the acyl chain region (e.g., a boron-dipyrromethene-labeled phospholipid), localizing the dye to the bilayer interior. These conjugates can be used to investigate bilayer packing, lipid mixing, and intracellular trafficking.
Sterol-anchored fluorophores: Cholesterol-fluorophore constructs (e.g., a boron-dipyrromethene-labeled cholesterol derivative) integrate into the LNP bilayer through the sterol anchor, providing a hydrophobic environment-stable probe useful for tracking lipid fate rather than the carrier as a whole.
The fluorophore-lipid conjugate is added to the ethanol phase at 0.1-1.0 mol% of total lipid before microfluidic mixing. Because the conjugate is covalently bound to a lipid anchor, it behaves identically to a regular lipid component during assembly. Loading optimization is primarily about balancing signal intensity against any perturbation of bilayer properties: at very high load (>2 mol%), some conjugates can shift bilayer phase behavior or modestly increase particle size. Standard purification by dialysis or TFF removes ethanol and free dye-related impurities. The labeled LNP is highly stable: in contrast to carbocyanine-labeled LNPs, conjugated lipid labels retain greater than 95% of fluorescence after 7-day incubation at 37 °C in serum-containing media, making them the preferred choice for longitudinal studies. Storage stability data is availablevia lipid nanoparticle stability characterization, including accelerated and long-term stability profiling.
Conjugated lipid-labeled LNPs are characterized by the same orthogonal battery used for other LNP labels. A key advantage is that the covalent anchor improves fluorophore retention within the labeled lipid, reducing concerns about free-dye artifacts. For biodistribution evaluation, the choice of fluorophore determines the appropriate imaging system. NBD and other visible-range fluorophores can be evaluated by confocal microscopy or flow cytometry, while longer-wavelength red or near-infrared fluorophores are better suited for tissue-level fluorescence measurements. When paired with ionizable lipid nanoparticles, conjugated lipid fluorophores can support biodistribution studies while enabling the labeled lipid component to be tracked across biological samples.
Conjugated lipid-labeled LNPs are the standard for quantitative biodistribution studies where signal integrity must be maintained over multiple days, for mechanistic studies probing lipid mixing and intracellular trafficking, and for applications where dye dissociation would invalidate downstream interpretation. Their main limitations are the higher cost of synthesis and the need to source or synthesize the conjugate before formulation. For laboratories requiring ready-made conjugates with defined anchor architectures, supplyvia custom synthesis partners is the practical path forward.
Table 3. Fluorophore-Conjugated Lipid Selection for LNP Biodistribution Studies.
| Conjugate | Ex / Em (nm) | Anchor Type | Localization in Bilayer | Recommended Loading | Best Suited For |
| NBD-PE | 460 / 534 | Phosphoethanolamine | Headgroup / aqueous interface | 0.5-1.0 mol% | Cell-surface binding; early endocytic tracking; environment-sensitive reporting |
| Acyl Chain-Labeled Fluorescent Phosphatidylcholine | 495 / 503 | Phosphocholine | Headgroup / aqueous interface | 0.3-0.8 mol% | General-purpose green labeling; multi-channel studies with dauer-type fluorophores |
| Boron-dipyrromethene-labeled phospholipid | 505 / 511 | Acyl chain | Bilayer interior | 0.3-0.8 mol% | Lipid mixing studies; intracellular trafficking; high-resolution imaging |
| Fluorophore-Conjugated Cholesterol | 495 / 503 | Sterol | Bilayer interior | 0.3-1.0 mol% | Tracking lipid/cholesterol fate; mechanistic studies of LNP disassembly |
BOC Sciences designs and synthesizes fluorophore-lipid conjugates with controlled anchor architecture and provides integrated characterization for long-term biodistribution studies.
PEG-anchored fluorophores — DSPE-PEG-fluorophore, DMG-PEG-fluorophore, and related constructs — represent the surface-directed counterpart to bilayer-embedded labels. The fluorophore is tethered to the LNP surface through a PEG spacer, projecting the dye into the surrounding aqueous phase. This surface presentation makes PEG-anchor labels particularly valuable for studying LNP-cell interactions, receptor binding, and the cellular uptake step specifically. Because the PEG spacer is the same chemistry used for pegylated lipid nanoparticles, the labeling approach integrates naturally with established LNP formulations without disturbing the ionizable lipid or helper lipid components.
Three parameters control PEG-anchor fluorophore performance:
PEG molecular weight: Spacers of 1-2 kDa project the dye close to the bilayer surface and are appropriate for studying receptor-ligand interactions. Spacers of 3-3.4 kDa provide greater accessibility for larger protein receptors and reduce steric hindrance in cellular uptake studies.
Anchor length (C14 vs. C18): DMG (C14) anchors desorb rapidly from the LNP surface upon dilution in serum, leading to dye release over hours. DSG (DPSE, C18) anchors remain stably associated, supporting longer-term tracking. The choice between fast-release and stable anchors allows intentional tuning of the labeling time window.
Surface density: Typical loadings of 0.1-1.0 mol% provide adequate signal without saturating the surface. Excessive PEG-anchor loading (>2 mol%) can paradoxically reduce cell uptake by sterically blocking ligand-receptor interactions.
The PEG-anchor-fluorophore construct is added to the ethanol phase before microfluidic mixing. Because the construct is already lipid-anchored, it requires no separate conjugation step; the LNP assembles with the fluorophore presented on the surface during the standard formulation process. After mixing and buffer exchange, the labeled LNP is characterized for size, PDI, zeta potential, and fluorescence. A key quality control is verifying that the PEG-anchor does not displace the stealth function of the parent PEG-lipid: zeta potential and colloidal stability in serum-containing media should remain unchanged relative to the unlabeled formulation. For formulation optimization, LNP PEG-lipid optimization services provide systematic screening of PEG length, anchor architecture, and density combinations.
PEG-anchor-labeled LNPs are particularly suited to flow cytometry and confocal microscopy because the surface-presented fluorophore is directly accessible to antibodies and cellular receptors. For in vivo biodistribution evaluation, the time window of the label must be considered: C14-anchor labels with rapid shedding provide short-term tracking (hours to a few days), while C18-anchor labels with stable association support multi-day imaging. PEG-anchor labeling is the standard when the research question specifically targets cell-surface interactions, receptor-mediated uptake, or the initial biodistribution step immediately after administration. Cellular-level resolution is enhanced by combining PEG-anchor labeling with nanoparticle cellular uptake testing and nanoparticle intracellular localization detection workflows.
PEG-anchor-labeled LNPs are the standard for studies of LNP-cell surface binding, receptor-mediated uptake, and acute biodistribution (first 24 hours). They are also useful for multi-modal studies where the LNP itself is labeled with one fluorophore while a separate cellular compartment (e.g., endosomes, lysosomes) is labeled with a spectrally distinct marker. Their main limitations are potential PEG-shedding artifacts (with C14 anchors) and steric effects on cell uptake at high loadings. They are less suitable for studies that require unambiguous tracking of the intact LNP over many days.
Table 4. Fluorophore-Conjugated PEG-Lipid Selection for LNP Biodistribution Studies.
| Construct | Ex / Em (nm) | PEG Length | Anchor | Recommended Density | Best Suited For |
| DSPE-PEG-FITC | 495 / 519 | 2 kDa | C18 (stable) | 0.3-1.0 mol% | Long-term tracking; standard flow cytometry; surface interaction studies |
| DMG-PEG-cyanine 5 | 646 / 662 | 2 kDa | C14 (shedding) | 0.2-0.8 mol% | Acute tracking (hours); release-on-internalization studies |
| DSPE-PEG-cyanine 5.5 | 673 / 707 | 3.4 kDa | C18 (stable) | 0.2-0.6 mol% | NIR whole-body imaging; long-term deep-tissue biodistribution |
| DSPE-PEG-Fluorescein | 495 / 519 | 2 kDa | C18 (stable) | 0.3-0.8 mol% | Photostable confocal imaging; multi-color studies; sensitive flow cytometry |
BOC Sciences provides PEG-anchor-fluorophore synthesis with tunable PEG length, anchor chemistry, and surface density for surface-directed biodistribution analysis.
Even with carefully selected fluorescent labels, biodistribution studies face recurring technical pitfalls that can invalidate data or produce misleading conclusions. Awareness of these failure modes is the foundation of robust experimental design.
Cause: Lipophilic dyes (DiD, DiR) partition into serum proteins and lipid carriers upon incubation with biological matrices. The free dye then redistributes independently of the LNP, producing tissue signal that does not represent intact LNP localization.
Indicator: Fluorescence detected in tissues with no expected LNP accumulation (e.g., kidney for an LNP that does not undergo renal clearance); signal patterns inconsistent with known LNP biodistribution; signal persisting long after intact LNP would have cleared.
Proposed Solution: Use covalently attached fluorophores (conjugated lipids or PEG-anchor constructs) for studies longer than 24 hours; include free-dye control groups at matched dye doses; verify LNP integrity in plasma ex vivo by size-exclusion chromatography before imaging.
Cause: At high dye loading, fluorophores in close proximity undergo static-or quenching or self-quenching through pi-pi stacking or resonance energy transfer. The relationship between dye loading and signal intensity is no longer linear.
Indicator: Signal intensity plateaus or decreases above a critical loading; apparent biodistribution depends non-linearly on administered LNP dose.
Proposed Solution: Titrate dye loading for each new LNP formulation and identify the linear regime; use calibration standards to convert signal to dye concentration; consider FRET pairs for distance-dependent studies where controlled quenching is intentional.
Cause: Tissue homogenates contain both intact LNP and any released dye, producing mixed fluorescence signals that cannot be distinguished by wavelength alone.
Indicator: Biodistribution patterns differ between labeled LNP and matched free-dye controls; signal-to-noise decreases over time in a manner inconsistent with LNP clearance kinetics.
Proposed Solution: Run free-dye control animals at the same dye dose as the labeled LNP group; use tandem techniques (e.g., mass spectrometry or radiolabeled cargo) to independently quantify LNP and dye signals; for critical experiments, use dual-labeling approaches where the LNP carries two spectrally distinct fluorophores with different dissociation kinetics.
Cause: Biodistribution profiles in mice do not linearly translate to larger species. Differences in body size, organ-to-body-weight ratios, lymphatic drainage, plasma protein profiles, and reticuloendothelial system activity all alter LNP fate.
Indicator: Organ accumulation ratios (e.g., liver-to-spleen) shift across species; subcutaneous and intramuscular administration routes produce different lymphatic drainage profiles in different species; immune cell uptake patterns (e.g., Kupffer cell vs. hepatic sinusoidal cell dominance) shift with body size.
Proposed Solution: Acknowledge species differences explicitly in study interpretation; design species-appropriate imaging protocols; for translational programs, validate key findings in at least two species before drawing conclusions; consider that pharmacological effects seen in mouse biodistribution may be attenuated in larger species.
BOC Sciences provides systematic troubleshooting for dye dissociation, signal distortion, free-dye contamination, and species-specific differences to ensure robust and reproducible biodistribution data.
BOC Sciences provides integrated scientific and manufacturing support spanning the entire fluorescent LNP biodistribution workflow — from labeling strategy selection through in vivo imaging and cellular-level analysis. Whether the project requires rapid carbocyanine labeling for formulation screening, NIR cyanine conjugation for whole-body imaging, or covalent lipid-fluorophore constructs for long-term tracking, the platform offers tailored solutions.
The starting point of any fluorescent LNP study is the labeling strategy selection, which depends on the research question, the imaging modality, the required time window, and the tolerance for dye dissociation. BOC Sciences provides consultative support to match each project to the most appropriate label chemistry, drawing on the four classes of fluorophore labeling (carbocyanine, NIR cyanine, conjugated lipid, PEG-anchor) described in this resource. Custom fluorescent LNP preparation includes dye-to-lipid optimization, microfluidic formulation at any scale from micrograms to grams, and full physicochemical characterization of the labeled product. For projects requiring specialized constructs (non-standard dye-lipid pairs, dual-labeled LNPs, ligand-modified fluorescent LNPs), lipid nanoparticle formulation services provide custom development.
Before any in vivo study, fluorescent LNPs must be rigorously characterized to confirm that the labeling step has not compromised the formulation. BOC Sciences provides comprehensivenanoparticle analysis and characterization services covering particle size and PDI by DLS, zeta potential, fluorescence spectroscopy (excitation, emission, intensity), encapsulation efficiency, payload integrity, and colloidal stability in serum-containing conditions. Long-term stability assessment under accelerated and real-time conditions confirms that the fluorescent signal remains associated with the LNP throughout the intended study window. This characterization battery produces the QC data package required for both internal decision-making and external study documentation.
BOC Sciences provides integrated nanoparticle in vivo imaging services covering the full temporal and spatial resolution spectrum appropriate to fluorescent LNP studies. Whole-body imaging by small-animal fluorescence imaging or equivalent systems tracks the temporal trajectory of LNP accumulation across major organs, while high-resolution organ-level imaging provides quantitative biodistribution data at study termination. Cellular-level biodistribution is resolved by flow cytometry on dissociated tissues, identifying which cell populations (hepatocytes, Kupffer cells, endothelial cells, immune cell subsets) have internalized the LNP. The integrated workflow produces publication-grade biodistribution data sets with appropriate controls, calibration curves, and PK metrics.
Table 5. BOC Sciences Services for Fluorescent LNP Biodistribution Studies.
| Service | Scope of Service | Key Deliverables | Inquiry |
| Custom Fluorescent LNP Preparation | Selection of label chemistry, dye-to-lipid optimization, microfluidic formulation at multiple scales, dual-label and multi-modal LNP preparation | Labeled LNPs with defined size, PDI, zeta potential, EE%, and fluorescence intensity; formulation report | Inquiry |
| Fluorophore-Lipid Conjugate Synthesis | Custom synthesis of dye-lipid conjugates including lipid-fluorophore, PEG-lipid-fluorophore, and sterol-fluorophore constructs with defined anchor architecture | Synthesized conjugates; conjugation efficiency data; purification report | Inquiry |
| Microfluidic LNP Production | Microfluidic process optimization for fluorescent LNP production, scale-up from microgram to gram quantities, batch consistency validation | Scalable manufacturing process with defined CPPs; multiple development batches with QC data | Inquiry |
| Labeled LNP Physicochemical Characterization | DLS, zeta potential, fluorescence spectroscopy, EE%, payload integrity, colloidal stability assessment | Comprehensive QC report; physicochemical fingerprint for each batch | Inquiry |
| Fluorescent Signal Stability Profiling | Accelerated and real-time stability assessment, dye retention kinetics, free-dye quantification over time | Stability report; signal retention data; recommended storage conditions | Inquiry |
| In Vivo Biodistribution Evaluation | Whole-body small-animal fluorescence imaging imaging, ex vivo organ imaging, quantitative tissue biodistribution, PK metric calculation | Temporal and organ-level biodistribution data; %ID/g and AUC analysis | Inquiry |
| Cellular Uptake and Trafficking Analysis | Flow cytometry on dissociated tissues, cell-type-specific uptake quantification, intracellular localization by confocal microscopy | Cell-population-level uptake data; subcellular localization analysis | Inquiry |
Fluorescent labeling has become the operational backbone of LNP biodistribution research, providing the direct visualization and quantitative measurement that formulation science requires. The four major labeling strategies — lipophilic carbocyanine dyes, NIR cyanine conjugates, fluorophore-conjugated lipids, and PEG-anchor fluorophores — each address distinct research questions with different strengths and limitations. Selecting the right strategy for a given study requires consideration of the imaging platform, the required time window, the tolerance for dye dissociation, and the need for cell-level resolution. The recurring challenges of dye dissociation, self-quenching, free-dye contamination, and species translation demand rigorous experimental controls and orthogonal validation. For research teams developing fluorescent LNP biodistribution studies, BOC Sciences offers integrated scientific and analytical support — from labeling strategy selection and custom synthesis, through microfluidic formulation and characterization, to whole-body imaging and cellular-level analysis — enabling the translation of fluorescence readouts into trustworthy, mechanistic insight into LNP fate in vivo.
